During the past decade, True North Clinical Research - Halifax conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 14 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 11 clinical trials were completed. i.e. 64.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "True North Clinical Research - Halifax" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "AstraZeneca" with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "TauRx Therapeutics Ltd" with 3 trials sponsored and "AEON Biopharma, Inc." with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "True North Clinical Research - Halifax" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "PPD" with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Anavex Australia Pty Ltd." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "True North Clinical Research - Halifax" are "Alzheimer's Disease" (12 trials), "Alzheimer Disease" (11 trials), "Depressive Disorder, Major" (2 trials), "Down Syndrome" (2 trials) and "Early Alzheimer's Disease" (2 trials). Many other conditions were trialed in "True North Clinical Research - Halifax" in a lesser frequency.

Most popular intervention types in "True North Clinical Research - Halifax" are "Drug" (37 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Gantenerumab" (5 trials), "Lanabecestat" (3 trials), "ABP-450" (2 trials) and "Aticaprant" (2 trials). Other intervention names were less common.

The vast majority of trials in "True North Clinical Research - Halifax" are 39 trials for "All" genders.

Currently, there are NaN active trials in "True North Clinical Research - Halifax". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in True North Clinical Research - Halifax, 2 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in True North Clinical Research - Halifax, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".